78 related articles for article (PubMed ID: 15616635)
1. Aiming for quality as well as quantity.
Jack DB
Drug News Perspect; 1998 Dec; 11(10):653-7. PubMed ID: 15616635
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Long-Term suppression of HIV infection: benefits and limitations of current treatment options.
Sension MG
J Assoc Nurses AIDS Care; 2007; 18(1 Suppl):S2-10. PubMed ID: 17275719
[TBL] [Abstract][Full Text] [Related]
4. AIDS in the Third World: how to stop the HIV infection?
De Clercq E
Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
[TBL] [Abstract][Full Text] [Related]
5. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
6. TDM: the key to more effective HIV treatment?
Jack D
Drug News Perspect; 2000 Dec; 13(10):622-7. PubMed ID: 12879133
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy in HIV infection--fourth international congress. 8-12 November 1998, Glasgow, Scotland.
Wainberg MA
IDrugs; 1999 Jan; 2(1):18-9. PubMed ID: 16180161
[TBL] [Abstract][Full Text] [Related]
8. Recent and future therapeutic advances in the management of HIV infection.
Saliba G; Yeni P
Pathol Biol (Paris); 2006 Dec; 54(10):545-50. PubMed ID: 17027195
[TBL] [Abstract][Full Text] [Related]
9. Update on HAART in HIV.
Yeni P
J Hepatol; 2006; 44(1 Suppl):S100-3. PubMed ID: 16359748
[TBL] [Abstract][Full Text] [Related]
10. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
11. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
Li J; Jiao LY; Li HP; Li L; Liu YJ; Zhuang DM; Liu SY; Bao ZY; Li H; Wang Z; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
[TBL] [Abstract][Full Text] [Related]
12. Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients.
Napravnik S; Keys JR; Quinlivan EB; Wohl DA; Mikeal OV; Eron JJ
AIDS; 2007 Apr; 21(7):825-34. PubMed ID: 17415037
[TBL] [Abstract][Full Text] [Related]
13. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both?
Holtgrave DR
Int J STD AIDS; 2005 Dec; 16(12):777-81. PubMed ID: 16336756
[TBL] [Abstract][Full Text] [Related]
14. Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.
Ware NC; Wyatt MA; Tugenberg T
Soc Sci Med; 2005 Aug; 61(3):565-76. PubMed ID: 15899316
[TBL] [Abstract][Full Text] [Related]
15. The influence of the M184V mutation in HIV-1 reverse transcriptase on the virological outcome of highly active antiretroviral therapy regimens with or without didanosine.
Sproat M; Pozniak AL; Peeters M; Winters B; Hoetelmans R; Graham NM; Gazzard BG
Antivir Ther; 2005; 10(2):357-61. PubMed ID: 15865231
[TBL] [Abstract][Full Text] [Related]
16. [Addiction and brief-systemic therapy: working with compulsion].
Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and basic researches on HIV/AIDS].
Cao YZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):609-12. PubMed ID: 17121215
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral regimens for treatment-experienced patients with HIV-1 infection.
Lagnese M; Daar ES
Expert Opin Pharmacother; 2008 Apr; 9(5):687-700. PubMed ID: 18345948
[TBL] [Abstract][Full Text] [Related]
19. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Cuzin L; Allavena C; Morlat P; Dellamonica P
AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
[TBL] [Abstract][Full Text] [Related]
20. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review].
Vladusić I; Krajinović V; Begovac J
Acta Med Croatica; 2006 Jun; 60(3):259-63. PubMed ID: 16933840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
